NADER EL-MALLAWANY

Concepts (210)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
14
2023
120
6.170
Why?
Epstein-Barr Virus Infections
11
2024
292
3.530
Why?
HIV Infections
16
2023
1896
2.380
Why?
Burkitt Lymphoma
9
2024
144
2.310
Why?
Herpesvirus 4, Human
9
2024
674
2.210
Why?
Herpesvirus 8, Human
3
2023
49
1.670
Why?
Lymphoma
4
2023
324
1.580
Why?
Malawi
17
2025
396
1.390
Why?
Lymphoproliferative Disorders
5
2024
224
1.250
Why?
Lymphoma, Non-Hodgkin
4
2023
164
1.240
Why?
Histiocytosis, Langerhans-Cell
4
2024
225
1.230
Why?
Lymphohistiocytosis, Hemophagocytic
2
2021
145
1.230
Why?
Lymphoma, T-Cell, Peripheral
1
2025
15
0.960
Why?
Child
41
2025
24462
0.940
Why?
Organ Transplantation
2
2024
165
0.930
Why?
Lymphoma, Large B-Cell, Diffuse
3
2024
143
0.820
Why?
Kasabach-Merritt Syndrome
1
2023
16
0.820
Why?
Lymphoma, T-Cell
4
2021
65
0.750
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2024
1237
0.700
Why?
Adolescent
27
2025
19331
0.680
Why?
Interleukin-6
2
2019
421
0.670
Why?
Disease Susceptibility
1
2021
296
0.660
Why?
Anemia
2
2023
340
0.640
Why?
Viral Load
4
2018
385
0.610
Why?
Antiretroviral Therapy, Highly Active
3
2020
269
0.590
Why?
Cytokines
3
2021
1290
0.580
Why?
Herpesviridae Infections
1
2018
142
0.570
Why?
Humans
53
2025
124809
0.520
Why?
Vincristine
5
2020
195
0.520
Why?
Antineoplastic Agents
3
2020
1668
0.450
Why?
Lymphoma, B-Cell
2
2025
142
0.420
Why?
Hematopoietic Stem Cell Transplantation
5
2025
1196
0.390
Why?
Rituximab
3
2024
157
0.390
Why?
Child, Preschool
16
2025
14054
0.390
Why?
Neoplasms
4
2025
2789
0.380
Why?
Methotrexate
3
2025
341
0.380
Why?
Hydroa Vacciniforme
1
2010
3
0.350
Why?
Male
27
2025
61306
0.330
Why?
AIDS-Related Opportunistic Infections
2
2020
136
0.320
Why?
Disease Management
2
2025
521
0.320
Why?
Young Adult
12
2024
8991
0.310
Why?
Female
27
2025
66575
0.310
Why?
Tanzania
3
2023
68
0.290
Why?
T-Lymphocytes, Cytotoxic
1
2010
501
0.280
Why?
Prognosis
6
2025
4615
0.280
Why?
Bone Marrow
3
2021
325
0.270
Why?
Neoplasm Staging
3
2019
1228
0.260
Why?
Immunotherapy
4
2022
665
0.260
Why?
Prospective Studies
8
2025
6138
0.260
Why?
Retrospective Studies
9
2025
16294
0.250
Why?
Laboratories, Hospital
1
2025
21
0.240
Why?
Skin Neoplasms
3
2023
806
0.240
Why?
Infant
9
2025
12488
0.240
Why?
Doxorubicin
3
2020
298
0.220
Why?
Socioeconomic Factors
2
2017
872
0.220
Why?
Antimetabolites, Antineoplastic
1
2025
181
0.220
Why?
Proto-Oncogene Proteins c-bcl-2
1
2024
173
0.210
Why?
Lymphomatoid Papulosis
1
2023
3
0.210
Why?
Cyclophosphamide
3
2020
422
0.210
Why?
Mycosis Fungoides
1
2023
15
0.210
Why?
Treatment Outcome
11
2025
12341
0.210
Why?
HIV-1
2
2016
467
0.200
Why?
Adult
9
2024
29482
0.200
Why?
Mucositis
1
2022
18
0.200
Why?
Morbidity
1
2023
244
0.200
Why?
Haploinsufficiency
1
2024
257
0.200
Why?
Africa South of the Sahara
2
2020
115
0.200
Why?
MAP Kinase Signaling System
1
2024
316
0.200
Why?
Molecular Targeted Therapy
2
2015
354
0.200
Why?
Translocation, Genetic
1
2024
356
0.190
Why?
Medical Oncology
1
2023
213
0.190
Why?
Perforin
1
2021
17
0.190
Why?
Killer Cells, Natural
2
2021
324
0.180
Why?
Virus Replication
1
2023
611
0.170
Why?
Cysticercosis
1
2020
21
0.170
Why?
T-Lymphocyte Subsets
1
2021
195
0.170
Why?
Bleomycin
2
2020
150
0.170
Why?
Pregnancy Complications, Neoplastic
1
2020
61
0.170
Why?
Protein Kinase Inhibitors
1
2024
530
0.170
Why?
Lymphadenopathy
1
2019
29
0.160
Why?
Anthracyclines
2
2017
36
0.160
Why?
Tertiary Healthcare
1
2019
21
0.160
Why?
Clinical Decision-Making
1
2021
267
0.160
Why?
Endemic Diseases
1
2018
57
0.150
Why?
HIV Protease Inhibitors
1
2018
54
0.150
Why?
Anti-HIV Agents
2
2020
315
0.150
Why?
Virus Activation
1
2018
87
0.150
Why?
Biopsy
1
2021
1239
0.140
Why?
Withholding Treatment
1
2017
68
0.140
Why?
Hodgkin Disease
2
2017
293
0.140
Why?
Asia
1
2017
107
0.140
Why?
Plasma
1
2017
98
0.130
Why?
Europe
1
2017
354
0.130
Why?
HIV
1
2017
180
0.130
Why?
Risk
1
2017
757
0.120
Why?
Developing Countries
1
2017
269
0.120
Why?
Remission Induction
1
2016
302
0.120
Why?
Cross-Sectional Studies
1
2023
3447
0.120
Why?
Angiomatosis, Bacillary
1
2014
3
0.120
Why?
Algorithms
1
2021
1616
0.110
Why?
Risk Factors
4
2023
10274
0.110
Why?
Pilot Projects
1
2018
1402
0.110
Why?
T-Lymphocytes
3
2019
1709
0.110
Why?
Mass Spectrometry
1
2014
331
0.110
Why?
Proto-Oncogene Proteins B-raf
2
2024
170
0.100
Why?
Child Health Services
1
2013
87
0.100
Why?
Biomarkers
1
2021
3063
0.100
Why?
Adenoviridae Infections
1
2011
70
0.090
Why?
Neoplasm Recurrence, Local
3
2024
1135
0.090
Why?
Proteomics
1
2014
500
0.090
Why?
Patient-Centered Care
1
2013
224
0.090
Why?
Genetic Predisposition to Disease
1
2021
3143
0.090
Why?
Recurrence
2
2024
1427
0.090
Why?
Survival Rate
4
2017
2036
0.080
Why?
United States
2
2023
10875
0.080
Why?
Infant, Newborn
2
2025
8189
0.080
Why?
DNA, Viral
3
2017
480
0.080
Why?
Genomics
1
2017
1490
0.080
Why?
Clinical Trials as Topic
1
2013
1090
0.080
Why?
Transcriptome
1
2014
940
0.080
Why?
Diagnosis, Differential
2
2024
1894
0.070
Why?
Mutation
1
2021
5815
0.070
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2014
779
0.070
Why?
Cell Line, Tumor
1
2014
3342
0.070
Why?
Cell Proliferation
1
2014
2307
0.070
Why?
Follow-Up Studies
3
2025
5155
0.070
Why?
CD4 Lymphocyte Count
2
2018
232
0.070
Why?
Cell Differentiation
1
2014
1929
0.070
Why?
Prednisone
2
2019
275
0.070
Why?
Time Factors
1
2016
6312
0.060
Why?
Signal Transduction
1
2017
4542
0.060
Why?
Disease-Free Survival
2
2016
868
0.060
Why?
Lymph Nodes
2
2019
380
0.060
Why?
Adenine Nucleotides
1
2024
41
0.060
Why?
Arabinonucleosides
1
2024
32
0.060
Why?
Chromosomes, Human, Pair 8
1
2024
78
0.060
Why?
Drug Monitoring
1
2025
170
0.050
Why?
Chromosomes, Human, Pair 14
1
2024
100
0.050
Why?
Hyperplasia
1
2024
208
0.050
Why?
Biomarkers, Tumor
2
2024
1473
0.050
Why?
DNA Helicases
1
2024
227
0.050
Why?
Salvage Therapy
1
2024
194
0.050
Why?
Transplantation, Autologous
1
2022
298
0.050
Why?
Seroepidemiologic Studies
1
2021
121
0.050
Why?
Stem Cell Transplantation
1
2022
236
0.040
Why?
Creatinine
1
2022
389
0.040
Why?
Transplantation Conditioning
1
2022
324
0.040
Why?
Chromatin
1
2024
555
0.040
Why?
Anticestodal Agents
1
2020
3
0.040
Why?
Praziquantel
1
2020
11
0.040
Why?
Subcutaneous Tissue
1
2020
15
0.040
Why?
Taenia solium
1
2020
11
0.040
Why?
Autoimmunity
1
2021
173
0.040
Why?
Immunity
1
2021
189
0.040
Why?
Albendazole
1
2020
29
0.040
Why?
Paclitaxel
1
2020
125
0.040
Why?
Middle Aged
4
2024
26727
0.040
Why?
Acquired Immunodeficiency Syndrome
1
2020
235
0.040
Why?
Immunocompromised Host
1
2020
296
0.040
Why?
Genetic Association Studies
1
2021
777
0.040
Why?
Nuclear Proteins
1
2024
1272
0.040
Why?
Anti-Retroviral Agents
1
2019
141
0.040
Why?
Proto-Oncogenes
1
2017
37
0.040
Why?
Drug Therapy, Combination
1
2020
1161
0.030
Why?
Antibiotics, Antineoplastic
1
2017
128
0.030
Why?
Viremia
1
2016
128
0.030
Why?
Pregnancy Complications, Infectious
1
2020
449
0.030
Why?
Genetic Testing
1
2021
1004
0.030
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2014
3
0.030
Why?
Antigens, CD20
1
2014
37
0.030
Why?
Risk Assessment
2
2016
3436
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2014
63
0.030
Why?
Transcription Factors
1
2024
2609
0.030
Why?
Central Nervous System Neoplasms
1
2016
197
0.030
Why?
Antigens, CD19
1
2014
177
0.030
Why?
Proportional Hazards Models
1
2017
1351
0.030
Why?
Adoptive Transfer
1
2014
237
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
18
0.030
Why?
Botswana
1
2013
76
0.030
Why?
Longitudinal Studies
1
2016
1328
0.030
Why?
Child Nutrition Disorders
1
2013
75
0.030
Why?
Gene Expression
1
2017
1569
0.020
Why?
Mouth Neoplasms
1
2013
84
0.020
Why?
Health Services Accessibility
1
2017
607
0.020
Why?
Sex Factors
1
2016
1285
0.020
Why?
Liver
1
2019
1764
0.020
Why?
Recombinant Fusion Proteins
1
2014
768
0.020
Why?
Thrombocytopenia
1
2013
227
0.020
Why?
Animals
2
2024
34188
0.020
Why?
Incidence
1
2018
3144
0.020
Why?
Japan
1
2011
133
0.020
Why?
Receptors, Antigen, T-Cell
1
2014
482
0.020
Why?
Gene Expression Profiling
1
2017
1699
0.020
Why?
Transplantation, Homologous
1
2011
661
0.020
Why?
Cell Separation
1
2010
229
0.020
Why?
Age Factors
1
2016
2820
0.020
Why?
Kaplan-Meier Estimate
1
2011
1028
0.020
Why?
RNA, Viral
1
2011
541
0.020
Why?
Antibodies, Monoclonal
1
2014
1019
0.020
Why?
In Situ Hybridization, Fluorescence
1
2010
764
0.020
Why?
B-Lymphocytes
1
2011
531
0.020
Why?
Flow Cytometry
1
2010
803
0.020
Why?
Pregnancy
1
2020
7172
0.020
Why?
Combined Modality Therapy
1
2011
1248
0.020
Why?
Graft vs Host Disease
1
2011
541
0.020
Why?
Polymerase Chain Reaction
1
2011
1588
0.020
Why?
Mice
1
2024
17743
0.020
Why?
Chronic Disease
1
2011
1192
0.020
Why?
Immunohistochemistry
1
2010
1691
0.020
Why?
Aged
1
2024
19693
0.020
Why?
EL-MALLAWANY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (210)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_